rs763289805
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The ENST00000238682.8(TGFB3):c.557T>G(p.Ile186Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. I186I) has been classified as Likely benign.
Frequency
Consequence
ENST00000238682.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGFB3 | NM_003239.5 | c.557T>G | p.Ile186Ser | missense_variant | 3/7 | ENST00000238682.8 | NP_003230.1 | |
TGFB3 | NM_001329939.2 | c.557T>G | p.Ile186Ser | missense_variant | 4/8 | NP_001316868.1 | ||
TGFB3 | NM_001329938.2 | c.557T>G | p.Ile186Ser | missense_variant | 3/5 | NP_001316867.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGFB3 | ENST00000238682.8 | c.557T>G | p.Ile186Ser | missense_variant | 3/7 | 1 | NM_003239.5 | ENSP00000238682 | P1 | |
TGFB3-AS1 | ENST00000553732.1 | n.292A>C | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251352Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135842
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 18, 2024 | Has been reported in a patient with a hereditary connective tissue disorder (PMID: 35918752); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35903967, 35918752) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Nov 17, 2018 | - - |
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2024 | The p.I186S variant (also known as c.557T>G), located in coding exon 3 of the TGFB3 gene, results from a T to G substitution at nucleotide position 557. The isoleucine at codon 186 is replaced by serine, an amino acid with dissimilar properties. This variant has been reported in connective tissue disorder cohorts (Veatch OJ et al. BMC Med Genomics, 2022 Aug;15:169; Steinle J et al. Am J Med Genet A, 2022 Oct;188:3016-3023). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. - |
TGFB3-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 03, 2024 | The TGFB3 c.557T>G variant is predicted to result in the amino acid substitution p.Ile186Ser. This variant was reported as a variant of uncertain significance in an individual with connective tissue disorder (Veatch et al 2022. PubMed ID: 35918752). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Rienhoff syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 13, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TGFB3 protein function. ClinVar contains an entry for this variant (Variation ID: 410272). This variant has not been reported in the literature in individuals affected with TGFB3-related conditions. This sequence change replaces isoleucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 186 of the TGFB3 protein (p.Ile186Ser). This variant is present in population databases (rs763289805, gnomAD 0.0009%). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at